Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 2, 2000, Pages 137-145

  Aoki, Yoshiyasu ^a   Jones, Karen D ^a   Tosato, Giovanna ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; HEMATOPOIESIS; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

HEMATOPOIESIS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; REVIEW LITERATURE; SARCOMA, KAPOSI; VIRAL PROTEINS;

EID: 0034108527     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319351     Document Type: Review

References (76)

1. Chang Y, E Cesarman, MS Pessin, F Lee, J Culpepper, DM Knowles and PS Moore. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
2. Schulz TF. (1998). Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79: 1573-1591.
3. Neipel F, and B Fleckenstein. (1999). The role of HHV-8 in Kaposi's sarcoma. Semin Cancer Biol 9:151-164.
4. Schulz TF, and PS Moore. (1999). Response from Schulz and Moore. Trends Microbiol 7:311-312.
5. Gallo RC. (1998). The enigmas of Kaposi's sarcoma. Science 282:1837-1839.
6. Russo JJ, RA Bohenzky, MC Chien, J Chen, M Yan, D Maddalena, JP Parry, D Peruzzi, IS Edelman, Y Chang and PS Moore. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93:14862-14867.
7. Tosato G, KB Seamon, ND Goldman, PB Sehgal, LT May, GC Washington, KD Jones and SE Pike. (1988). Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). Science 239:502-504.
8. Tosato G, TL Gerrard, NG Goldman and SE Pike. (1988). Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6. J Immunol 140:4329-4336.
9. Kishimoto T, S Akira, M Narazaki and T Taga. (1995). Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
10. Tosato G, K Jones, MK Breinig, HP McWilliams and JL McKnight. (1993). Interleukin-6 production in posttransplant lymphoproliferative disease. J Clin Invest 91: 2806-2814.
11. Moore PS, C Boshoff, RA Weiss and Y Chang. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739-1744.
12. Neipel F, JC Albrecht, A Ensser, YQ Huang, JJ Li, AE Friedman-Kien and B Fleckenstein. (1997). Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71:839-842.
13. Snouwaert JN, FW Leebeek and DM Fowlkes. (1991). Role of disulfide bonds in biologic activity of human interleukin-6. J Biol Chem 266:23097-23102.
14. Somers W, M Stahl and JS Seehra. (1997). 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J 16:989-997.
15. Hirano T, K Yasukawa, H Harada, T Taga, Y Watanabe, T Matsuda, S Kashiwamura, K Nakajima, K Koyama, A Iwamatsu, S Tsunasawa, F Sakiyama, H Matsui, Y Takahara, T Taniguchi and T Kishimoto. (1986). Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73-76.
16. Li X, F Rock, P Chong, S Cockle, A Keating, H Ziltener and M Klein. (1993). Structure-function analysis of the C-terminal segment of human interleukin-6. J Biol Chem 268:22377-22384.
17. Kaleeba JA, EP Bergquam and SW Wong. (1999). A rhesus macaque rhadinovirus related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 encodes a functional homologue of interleukin-6. J Virol 73:6177-6181.
18. Nicholas J, VR Ruvolo, WH Burns, G Sandford, X Wan, D Ciufo, SB Hendrickson, HG Guo, GS Hayward and MS Reitz. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287-292.
19. Peters M, AM Muller and S Rose-John. (1998). Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 92:3495-3504.
20. Hammacher A, RT Richardson, JE Layton, DK Smith, LJ Angus, DJ Hilton, NA Nicola, J Wijdenes and RJ Simpson. (1998). The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J Biol Chem 273:22701-22707.
21. Brakenhoff JP, FD de Hon, V Fontaine, E ten Boekel, H Schooltink, S Rose-John, PC Heinrich, J Content and LA Aarden. (1994). Development of a human interleukin-6 receptor antagonist. J Biol Chem 269:86-93.
22. Burger R, F Neipel, B Fleckenstein, R Savino, G Ciliberto, JR Kalden and M Gramatzki. (1998). Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91:1858-1863.
23. Aoki Y, ES Jaffe, Y Chang, K Jones, J Teruya-Feldstein, PS Moore and G Tosato. (1999). Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93:4034-4043.
24. Molden J, Y Chang, Y You, PS Moore and MA Goldsmith. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272:19625-19631.
25. Liu Y, R de Waal Malefyt, F Briere, C Parham, JM Bridon, J Banchereau, KW Moore and J Xu. (1997). The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158:604-613.
26. Moore KW, P Vieira, DF Fiorentino, ML Trounstine, TA Khan and TR Mosmann. (1990). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230-1234.
27. Kotenko SV, CD Krause, LS Izotova, BP Pollack, W Wu and S Pestka. (1997). Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16:5894-5903.
28. Metcalf D. (1994). Hemopoietic regulators and leukemia development: a personal retrospective. Adv Cancer Res 63:41-91.
29. Ikebuchi K, GG Wong, SC Clark, JN Ihle, Y Hirai and M Ogawa. (1987). Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84:9035-9039.
30. Suematsu S, T Matsuda, K Aozasa, S Akira, N Nakano, S Ohno, J Miyazaki, K Yamamura, T Hirano and T Kishimoto. (1989). IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86:7547-7551.
31. Brandt SJ, DM Bodine, CE Dunbar and AW Nienhuis. (1990). Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 86:592-599.
32. Peters M, S Jacobs, M Ehlers, P Vollmer, J Mullberg, E Wolf, G Brem, KH Meyer zum Buschenfelde and S Rose-John. (1996). The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 183:1399-1406.
33. + cells. J Exp Med 184:1357-1364.
34. McKinstry WJ, CL Li, JE Rasko, NA Nicola, GR Johnson and D Metcalf. (1997). Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65-71.
35. Orfanos CE, R Husak, U Wolfer and C Garbe. (1995). Kaposi's sarcoma: a reevaluation. Recent Results Cancer Res 139:275-296.
36. Cohen T, D Nahari, LW Cerem, G Neufeld and BZ Levi. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736-741.
37. Paquet P, and GE Pierard. (1996). Interleukin-6 and the skin. Int Arch Allergy Immunol 109:308-317.
38. Masood R, J Cai, T Zheng, DL Smith, Y Naidu and PS Gill. (1997). Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979-984.
39. Arora N, R Masood, T Zheng, J Cai, DL Smith and PS Gill. (1999). Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res 59:183-188.
40. Veikkola T, and K Alitalo. (1999). VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220.
41. Boshoff C, Y Endo, PD Collins, Y Takeuchi, JD Reeves, VL Schweickart, MA Siani, T Sasaki, TJ Williams, PW Gray, PS Moore, Y Chang and RA Weiss. (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290-294.
42. Bais C, B Santomasso, O Coso, L Arvanitakis, EG Raaka, JS Gutkind, AS Asch, E Cesarman, MC Gershengorn, EA Mesri and MC Gerhengorn. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89.
43. Berenson JR, and RA Vescio. (1999). HHV-8 is present in multiple myeloma patients. Blood 93:3157-3159.
44. Tarte K, Y Chang and B Klein. (1999). Kaposi's sarcoma-associated herpesvirus and multiple myeloma: lack of criteria for causality. Blood 93:3159-3163.
45. Karp JE, JM Pluda and R Yarchoan. (1996). AIDS-related Kaposi's sarcoma. A template for the translation of molecular pathogenesis into targeted therapeutic approaches. Hematol Oncol Clin North Am 10:1031-1049.
46. Chatlynne LG, and DV Ablashi. (1999). Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 9:175-185.
47. Boshoff C, TF Schulz, MM Kennedy, AK Graham, C Fisher, A Thomas, JO McGee, RA Weiss and JJ O'Leary. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1:1274-1278.
48. Davis MA, MA Sturzl, C Blasig, A Schreier, HG Guo, M Reitz, SR Opalenik and PJ Browning. (1997). Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 89:1868-1874.
49. Dupin N, C Fisher, P Kellam, S Ariad, M Tulliez, N Franck, E van Marck, D Salmon, I Gorin, JP Escande, RA Weiss, K Alitalo and C Boshoff. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546-4551.
50. Staskus KA, R Sun, G Miller, P Racz, A Jaslowski, C Metroka, H Brett-Smith and AT Haase. (1999). Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease, J Virol 73:4181-4187.
51. Cannon JS, J Nicholas, JM Orenstein, RB Mann, PG Murray, PJ Browning, JA DiGiuseppe, E Cesarman, GS Hayward and RF Ambinder. (1999). Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J Infect Dis 180:824-828.
52. Miles SA, AR Rezai, JF Salazar-Gonzalez, M Vander Meyden, RH Stevens, DM Logan, RT Mitsuyasu, T Taga, T Hirano, T Kishimoto and O Martinezmaza. (1990). AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87:4068-4072.
53. Murakami-Mori K, T Taga, T Kishimoto and S Nakamura. (1995). AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. J Clin Invest 96: 1319-1327.
54. Sturzl M, H Brandstetter, C Zietz, B Eisenburg, G Raivich, DP Gearing, NH Brockmeyer and PH Hofschneider. (1995). Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene 10:2007-2016.
55. Wang XJ, T Taga, K Yoshida, M Saito, T Kishimoto and H Kikutani. (1998). gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. Blood 91: 3308-3314.
56. Cesarman E, and DM Knowles. (1997). Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin Diagn Pathol 14:54-66.
57. Matolcsy A, RG Nador, E Cesarman and DM Knowles. (1998). Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153: 1609-1614.
58. Gaidano G, D Capello, AM Cilia, A Gloghini, T Perin, S Quattrone, A Migliazza, F Lo Coco, G Saglio, V Ascoli and A Carbone. (1999). Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer 24:16-23.
59. Jones DK, Y Aoki, Y Chang, PS Moore, R Yarchoan and G Tosato. (1999). Involvement of IL-10 and viral IL-6 in the spontaneous growth of Kaposi's sarcoma associated-herpesvirus-infected primary effusion lymphoma cells. Blood 94:2871-2879.
60. Aoki A, and G Tosato. (1999). Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of KSHV-infected primary effusion lymphomas. Blood 94:4247-4254.
61. Aoki Y, G Tosato, Y Nambu, A Iwamoto and R Yarchoaw. (2000). Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas. Blood 95: 1109-1110.
62. Peterson BA, and G Frizzera. (1993). Multicentric Castleman's disease. Semin Oncol 20:636-647.
63. Foss HD, I Araujo, G Demel, H Klotzbach, M Hummel and H Stein. (1997). Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 183:44-50.
64. Chadburn A, E Cesarman, RG Nador, YF Liu and DM Knowles. (1997). Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 80:788-797.
65. Parravinci C, M Corbellino, M Paulli, U Magrini, M Lazzarino, PS Moore and Y Chang. (1997). Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 151:1517-1522.
66. Beck JT, SM Hsu, J Wijdenes, R Bataille, B Klein, D Vesole, K Hayden, S Jagannath and B Barlogie. (1994). Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330:602-605.
67. Rettig MB, HJ Ma, RA Vescio, M Pold, G Schiller, D Belson, A Savage, C Nishikubo, C Wu, J Fraser, JW Said and JR Berenson. (1997). Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients [see Comments]. Science 276: 1851-1854.
68. Tisdale JF, AK Stewart, B Dickstein, RF Little, I Dube, D Cappe, CE Dunbar and KE Brown. (1998). Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood 92:2681-2687.
69. Rabkin CS, TF Schulz, D Whitby, ET Lennette, LI Magpantay, L Chatlynne and RJ Biggar. (1998). Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 178: 304-309.
70. Masala G, S Di Lollo, C Picoco, P Crosignani, V Demicheli, A Fontana, I Funto, L Miligi, O Nanni, A Papucci, V Ramazzotti, S Rodella, E Stagnaro, R Tumino, C Vigano, C Vindigni, A Seniori Costantini and P Vineis. (1996). Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes. Int J Cancer 68:156-159.
71. Penn I. (1995). Sarcomas in organ allograft recipients. Transplantation 60:1485-1491.
72. Howard AD, J Moore, Jr., and M-M Tomaszewski. (1987). Occurrence of multiple myeloma three years after successful renal transplantation. Am J Kidney Dis 10:147-150.
73. Dagher F, D Sammelt, R Abbi, JR Tomasula, V Delaney, and KMH Butt. (1996). Renal transplantation in multiple myeloma. Transplantation 62:1577-1580.
74. Tarte K, SJ Olsen, JF Rossi, E Legouffe, ZY Lu, M Jourdan, Y Chang and B Klein. (1998). Kaposi's sarcoma-associated herpesvirus is not detected with immunosuppression in multiple myeloma. Blood 92:2186-2188.
75. Rosenzwajg M, N Fery, V Bons, G Damaj, E Gluckman and J Gluckman. (1999). Human herpesvirus 8 (HHV8) serology in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 24:351-354.
76. Hudnall SD, PL Rady, SK Tyring and JC Fish. (1998). Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients. J Infect Dis 178:1791-1794.